Is Rein Therapeutics RNTX stock testing important levels Q4 2025 Profit Disappoints IBTA Ibotta Q4 2025 EPS falls far short of estimates shares dip 213 percent on weak quarterly performance CoStar CSGP Volume Analysis Q4 2025 EPS Exceeds Expectations